Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • brentp
    Member
    • Apr 2010
    • 72

    #1

    DESeq on BS-Seq data

    Hi, would it be reasonable to use DESeq on Bisulfite data?

    I was thinking of using counts of the number of unconverted Cytosines (for different treatments) covering each gene as the input.
    Any reason I should *not* do that?
    Any thing I should be aware of in doing so?

    Thanks,
    Brent
  • brentp
    Member
    • Apr 2010
    • 72

    #2
    Or perhaps the counts would be better as number of Cytosines with > X% methylation within a gene?

    Comment

    • Wolfgang Huber
      Senior Member
      • Aug 2009
      • 109

      #3
      Dear Brent

      probably the answer is yes, but "use DESeq on Bisulfite data" is vague, and it will be good to first clarify: what is the biological question that you want to answer with this? How do you translate it into the hypothesis test(s) of DESeq?

      Whatever you do, can you first apply it to a comparison between biological replicates ("as if" they were the two conditions that you want to compare) and make sure that the type-I error (false positive rate or false discovery) is as advertised?

      Best wishes
      Wolfgang
      Wolfgang Huber
      EMBL

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:35 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...